Alexandra B. Maulden

FDA & OHRP Draft Guidance: Including Tissue Biopsies In Clinical Trials

DEA Tightens Buprenorphine Telemedicine Prescribing Rules

Medicare Telehealth Flexibilities Get A Three-Month Lifeline

Private Equity: Senators Markey And Braun Seek Information On Role In Treatment For Opioid Use Disorder

FDA Clinical Investigations: New Guidance On Electronic Systems

Substance Use Disorder Treatment Services: 2025 Physician Fee Schedule Proposed Rule Would Expand Access And Medicare Coverage

Clinical Trials: FDA Publishes Draft Guidance On Diversity Action Plans

2024 Health Care & Life Sciences Top Trends - Driving Tomorrow's Advances In The Health Care And Life Sciences Ecosystems

New Favorable OIG Advisory Opinion Allows Patient Assistant Programs Funded By Drug Manufacturers

Opioid Treatment Programs: SAMHSA Makes Permanent Regulatory Flexibilities